Last reviewed · How we verify
Corticosteroid with lidocaine with epinephrine
Corticosteroid with lidocaine with epinephrine, marketed by Vanderbilt University Medical Center, holds a niche position in the pharmaceutical market. The key composition patent expires in 2028, providing a competitive advantage through exclusive formulation rights. The primary risk is the lack of reported revenue and key trial results, which may limit market visibility and investor confidence.
At a glance
| Generic name | Corticosteroid with lidocaine with epinephrine |
|---|---|
| Sponsor | Vanderbilt University Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder (PHASE4)
- Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis (PHASE4)
- Ultrasound-Guided Suprascapular Nerve RFA vs Steroid-Local Anesthetic Injection in Chronic Shoulder Pain (NA)
- Frozen Shoulder and Hormone Replacement Therapy (PHASE4)
- One Cause of Heel Pain is Plantar Fasciopathy (PF). In Most Cases, a Heel Spur is Frequently Present Alongside PF. We Aim to Evaluate the Efficacy of Corticosteroid Injection and Radiofrequency Ablation, Along With Tissue Elasticity Assessed by Ultrasound, in Patients With Chronic Pain (≥6 Months). (NA)
- Comparison of Initial Treatment for Carpal Tunnel Syndrome Related to Rheumatic Diseases: Corticosteroid Injection Versus Nighttime Splinting (NA)
- Comparison of Corticosteroid Injection, Nighttime Splinting, or Their Combination for Initial Treatment of Moderate-to-Severe Carpal Tunnel Syndrome (NA)
- Biological Response to Platelet-rich Plasma and Corticosteroid Injections (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: